Advertisement

More articles from Notice of Retraction

You have access
Notice of Retraction: Tripathy S, Chapman JD, Han CY, Hogarth CA, Arnold SLM, Onken J, Kent T, Goodlett DR, and Isoherranen N (2016) All-trans-retinoic acid enhances mitochondrial function in models of human liver. Mol Pharmacol 89(5):560–574; doi:https://doi.org/10.1124/mol.116.103697
Molecular Pharmacology February 2020, 97 (2) 61; DOI: https://doi.org/10.1124/mol.116.103697retraction
You have access
Re: Dasmahapatra G, Almenara JA, and Grant S, “Flavopiridol and Histone Deacetylase Inhibitors Promote Mitochondrial Injury and Cell Death in Human Leukemia Cells that Overexpress Bcl-2.” Mol Pharmacol January 2006 69:288–298; doi:10.1124/mol.105.016154
Molecular Pharmacology April 2019, 95 (4) 335; DOI: https://doi.org/10.1124/mol.105.016154retraction
You have access
Re: Rosato RR, Maggio SC, Almenara JA, Payne SG, Atadja P, Spiegel S, Dent P, and Grant S, “The Histone Deacetylase Inhibitor LAQ824 Induces Human Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide.” Mol Pharmacol January 2006 69:216–225; doi:10.1124/mol.105.017145
Molecular Pharmacology April 2019, 95 (4) 336; DOI: https://doi.org/10.1124/mol.105.017145retraction
You have access
Re: Abkhezr M and Dryer SE (2014) Angiotensin II and Canonical Transient Receptor Potential-6 Activation Stimulate Release of a Signal Transducer and Activator of Transcription 3–Activating Factor from Mouse Podocytes Mol Pharmacol August 2014 86:150–158; doi:10.1124/mol.114.092536
Molecular Pharmacology September 2016, 90 (3) 160; DOI: https://doi.org/10.1124/mol.114.092536retraction
You have access
Re: Abkhezr M and Dryer SE (2015) STAT3 Regulates Steady-State Expression of Synaptopodin in Cultured Mouse Podocytes Mol Pharmacol February 2015 87:231–239; doi:10.1124/mol.114.094508
Molecular Pharmacology September 2016, 90 (3) 161; DOI: https://doi.org/10.1124/mol.115.094508retraction
You have access
Re: Takada Y, Sethi G, Sung B, and Aggarwal BB (2008) Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells Mol Pharmacol May 2008 73:1549–1557; doi:10.1124/mol.107.041350
Molecular Pharmacology July 2016, 90 (1) 63; DOI: https://doi.org/10.1124/mol.115.041350retraction
You have access
Re: Phromnoi K, Reuter S, Sung B, Prasad S, Kannappan R, Yadav VR, Chanmahasathien W, Limtrakul P, and Aggarwal BB (2010) A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents. Mol Pharmacol 79:279–289; doi:10.1124/mol.110.067512
Molecular Pharmacology July 2016, 90 (1) 64; DOI: https://doi.org/10.1124/mol.115.067512retraction
You have access
Re: Henschler R, Brennscheidt U, Mertelsmann R, and Herrmann F (1991) Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-β-d-arabinofuranosylcytosine. Mol Pharmacol 39:171-176
Molecular Pharmacology January 2007, 71 (1) 388; DOI: https://doi.org/10.1124/mol.71.1.388